Report ID: GIR2212260089 | Category: Pharma & Healthcare | Pages: 99 | Format: PDF | Published Date: February 04,2023
1 Market Overview 1.1 Product Overview and Scope of Vortioxetine Hydrobromide Tablets 1.2 Market Estimation Caveats and Base Year 1.3 Market Analysis by Type 1.3.1 Overview: Global Vortioxetine Hydrobromide Tablets Consumption Value by Type: 2018 Versus 2022 Versus 2029 1.3.2 5mg 1.3.3 10mg 1.3.4 20mg 1.4 Market Analysis by Application 1.4.1 Overview: Global Vortioxetine Hydrobromide Tablets Consumption Value by Application: 2018 Versus 2022 Versus 2029 1.4.2 Antidepressants 1.4.3 Anxiolytics 1.5 Global Vortioxetine Hydrobromide Tablets Market Size & Forecast 1.5.1 Global Vortioxetine Hydrobromide Tablets Consumption Value (2018 & 2022 & 2029) 1.5.2 Global Vortioxetine Hydrobromide Tablets Sales Quantity (2018-2029) 1.5.3 Global Vortioxetine Hydrobromide Tablets Average Price (2018-2029) 2 Manufacturers Profiles 2.1 H.Lundbeck A/S 2.1.1 H.Lundbeck A/S Details 2.1.2 H.Lundbeck A/S Major Business 2.1.3 H.Lundbeck A/S Vortioxetine Hydrobromide Tablets Product and Services 2.1.4 H.Lundbeck A/S Vortioxetine Hydrobromide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.1.5 H.Lundbeck A/S Recent Developments/Updates 2.2 Kanghong Pharmaceutical 2.2.1 Kanghong Pharmaceutical Details 2.2.2 Kanghong Pharmaceutical Major Business 2.2.3 Kanghong Pharmaceutical Vortioxetine Hydrobromide Tablets Product and Services 2.2.4 Kanghong Pharmaceutical Vortioxetine Hydrobromide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.2.5 Kanghong Pharmaceutical Recent Developments/Updates 2.3 Takeda Pharmaceuticals USA 2.3.1 Takeda Pharmaceuticals USA Details 2.3.2 Takeda Pharmaceuticals USA Major Business 2.3.3 Takeda Pharmaceuticals USA Vortioxetine Hydrobromide Tablets Product and Services 2.3.4 Takeda Pharmaceuticals USA Vortioxetine Hydrobromide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.3.5 Takeda Pharmaceuticals USA Recent Developments/Updates 2.4 Takeda Pharmaceutical 2.4.1 Takeda Pharmaceutical Details 2.4.2 Takeda Pharmaceutical Major Business 2.4.3 Takeda Pharmaceutical Vortioxetine Hydrobromide Tablets Product and Services 2.4.4 Takeda Pharmaceutical Vortioxetine Hydrobromide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.4.5 Takeda Pharmaceutical Recent Developments/Updates 2.5 Zydus Pharms 2.5.1 Zydus Pharms Details 2.5.2 Zydus Pharms Major Business 2.5.3 Zydus Pharms Vortioxetine Hydrobromide Tablets Product and Services 2.5.4 Zydus Pharms Vortioxetine Hydrobromide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.5.5 Zydus Pharms Recent Developments/Updates 2.6 CSPC Ouyi Pharmaceutical 2.6.1 CSPC Ouyi Pharmaceutical Details 2.6.2 CSPC Ouyi Pharmaceutical Major Business 2.6.3 CSPC Ouyi Pharmaceutical Vortioxetine Hydrobromide Tablets Product and Services 2.6.4 CSPC Ouyi Pharmaceutical Vortioxetine Hydrobromide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.6.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates 2.7 Brilliant Pharmaceutical 2.7.1 Brilliant Pharmaceutical Details 2.7.2 Brilliant Pharmaceutical Major Business 2.7.3 Brilliant Pharmaceutical Vortioxetine Hydrobromide Tablets Product and Services 2.7.4 Brilliant Pharmaceutical Vortioxetine Hydrobromide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.7.5 Brilliant Pharmaceutical Recent Developments/Updates 2.8 Chiatai Tianqing 2.8.1 Chiatai Tianqing Details 2.8.2 Chiatai Tianqing Major Business 2.8.3 Chiatai Tianqing Vortioxetine Hydrobromide Tablets Product and Services 2.8.4 Chiatai Tianqing Vortioxetine Hydrobromide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.8.5 Chiatai Tianqing Recent Developments/Updates 2.9 Sino Biopharmaceutical 2.9.1 Sino Biopharmaceutical Details 2.9.2 Sino Biopharmaceutical Major Business 2.9.3 Sino Biopharmaceutical Vortioxetine Hydrobromide Tablets Product and Services 2.9.4 Sino Biopharmaceutical Vortioxetine Hydrobromide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.9.5 Sino Biopharmaceutical Recent Developments/Updates 3 Competitive Environment: Vortioxetine Hydrobromide Tablets by Manufacturer 3.1 Global Vortioxetine Hydrobromide Tablets Sales Quantity by Manufacturer (2018-2023) 3.2 Global Vortioxetine Hydrobromide Tablets Revenue by Manufacturer (2018-2023) 3.3 Global Vortioxetine Hydrobromide Tablets Average Price by Manufacturer (2018-2023) 3.4 Market Share Analysis (2022) 3.4.1 Producer Shipments of Vortioxetine Hydrobromide Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2022 3.4.2 Top 3 Vortioxetine Hydrobromide Tablets Manufacturer Market Share in 2022 3.4.2 Top 6 Vortioxetine Hydrobromide Tablets Manufacturer Market Share in 2022 3.5 Vortioxetine Hydrobromide Tablets Market: Overall Company Footprint Analysis 3.5.1 Vortioxetine Hydrobromide Tablets Market: Region Footprint 3.5.2 Vortioxetine Hydrobromide Tablets Market: Company Product Type Footprint 3.5.3 Vortioxetine Hydrobromide Tablets Market: Company Product Application Footprint 3.6 New Market Entrants and Barriers to Market Entry 3.7 Mergers, Acquisition, Agreements, and Collaborations 4 Consumption Analysis by Region 4.1 Global Vortioxetine Hydrobromide Tablets Market Size by Region 4.1.1 Global Vortioxetine Hydrobromide Tablets Sales Quantity by Region (2018-2029) 4.1.2 Global Vortioxetine Hydrobromide Tablets Consumption Value by Region (2018-2029) 4.1.3 Global Vortioxetine Hydrobromide Tablets Average Price by Region (2018-2029) 4.2 North America Vortioxetine Hydrobromide Tablets Consumption Value (2018-2029) 4.3 Europe Vortioxetine Hydrobromide Tablets Consumption Value (2018-2029) 4.4 Asia-Pacific Vortioxetine Hydrobromide Tablets Consumption Value (2018-2029) 4.5 South America Vortioxetine Hydrobromide Tablets Consumption Value (2018-2029) 4.6 Middle East and Africa Vortioxetine Hydrobromide Tablets Consumption Value (2018-2029) 5 Market Segment by Type 5.1 Global Vortioxetine Hydrobromide Tablets Sales Quantity by Type (2018-2029) 5.2 Global Vortioxetine Hydrobromide Tablets Consumption Value by Type (2018-2029) 5.3 Global Vortioxetine Hydrobromide Tablets Average Price by Type (2018-2029) 6 Market Segment by Application 6.1 Global Vortioxetine Hydrobromide Tablets Sales Quantity by Application (2018-2029) 6.2 Global Vortioxetine Hydrobromide Tablets Consumption Value by Application (2018-2029) 6.3 Global Vortioxetine Hydrobromide Tablets Average Price by Application (2018-2029) 7 North America 7.1 North America Vortioxetine Hydrobromide Tablets Sales Quantity by Type (2018-2029) 7.2 North America Vortioxetine Hydrobromide Tablets Sales Quantity by Application (2018-2029) 7.3 North America Vortioxetine Hydrobromide Tablets Market Size by Country 7.3.1 North America Vortioxetine Hydrobromide Tablets Sales Quantity by Country (2018-2029) 7.3.2 North America Vortioxetine Hydrobromide Tablets Consumption Value by Country (2018-2029) 7.3.3 United States Market Size and Forecast (2018-2029) 7.3.4 Canada Market Size and Forecast (2018-2029) 7.3.5 Mexico Market Size and Forecast (2018-2029) 8 Europe 8.1 Europe Vortioxetine Hydrobromide Tablets Sales Quantity by Type (2018-2029) 8.2 Europe Vortioxetine Hydrobromide Tablets Sales Quantity by Application (2018-2029) 8.3 Europe Vortioxetine Hydrobromide Tablets Market Size by Country 8.3.1 Europe Vortioxetine Hydrobromide Tablets Sales Quantity by Country (2018-2029) 8.3.2 Europe Vortioxetine Hydrobromide Tablets Consumption Value by Country (2018-2029) 8.3.3 Germany Market Size and Forecast (2018-2029) 8.3.4 France Market Size and Forecast (2018-2029) 8.3.5 United Kingdom Market Size and Forecast (2018-2029) 8.3.6 Russia Market Size and Forecast (2018-2029) 8.3.7 Italy Market Size and Forecast (2018-2029) 9 Asia-Pacific 9.1 Asia-Pacific Vortioxetine Hydrobromide Tablets Sales Quantity by Type (2018-2029) 9.2 Asia-Pacific Vortioxetine Hydrobromide Tablets Sales Quantity by Application (2018-2029) 9.3 Asia-Pacific Vortioxetine Hydrobromide Tablets Market Size by Region 9.3.1 Asia-Pacific Vortioxetine Hydrobromide Tablets Sales Quantity by Region (2018-2029) 9.3.2 Asia-Pacific Vortioxetine Hydrobromide Tablets Consumption Value by Region (2018-2029) 9.3.3 China Market Size and Forecast (2018-2029) 9.3.4 Japan Market Size and Forecast (2018-2029) 9.3.5 Korea Market Size and Forecast (2018-2029) 9.3.6 India Market Size and Forecast (2018-2029) 9.3.7 Southeast Asia Market Size and Forecast (2018-2029) 9.3.8 Australia Market Size and Forecast (2018-2029) 10 South America 10.1 South America Vortioxetine Hydrobromide Tablets Sales Quantity by Type (2018-2029) 10.2 South America Vortioxetine Hydrobromide Tablets Sales Quantity by Application (2018-2029) 10.3 South America Vortioxetine Hydrobromide Tablets Market Size by Country 10.3.1 South America Vortioxetine Hydrobromide Tablets Sales Quantity by Country (2018-2029) 10.3.2 South America Vortioxetine Hydrobromide Tablets Consumption Value by Country (2018-2029) 10.3.3 Brazil Market Size and Forecast (2018-2029) 10.3.4 Argentina Market Size and Forecast (2018-2029) 11 Middle East & Africa 11.1 Middle East & Africa Vortioxetine Hydrobromide Tablets Sales Quantity by Type (2018-2029) 11.2 Middle East & Africa Vortioxetine Hydrobromide Tablets Sales Quantity by Application (2018-2029) 11.3 Middle East & Africa Vortioxetine Hydrobromide Tablets Market Size by Country 11.3.1 Middle East & Africa Vortioxetine Hydrobromide Tablets Sales Quantity by Country (2018-2029) 11.3.2 Middle East & Africa Vortioxetine Hydrobromide Tablets Consumption Value by Country (2018-2029) 11.3.3 Turkey Market Size and Forecast (2018-2029) 11.3.4 Egypt Market Size and Forecast (2018-2029) 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029) 11.3.6 South Africa Market Size and Forecast (2018-2029) 12 Market Dynamics 12.1 Vortioxetine Hydrobromide Tablets Market Drivers 12.2 Vortioxetine Hydrobromide Tablets Market Restraints 12.3 Vortioxetine Hydrobromide Tablets Trends Analysis 12.4 Porters Five Forces Analysis 12.4.1 Threat of New Entrants 12.4.2 Bargaining Power of Suppliers 12.4.3 Bargaining Power of Buyers 12.4.4 Threat of Substitutes 12.4.5 Competitive Rivalry 12.5 Influence of COVID-19 and Russia-Ukraine War 12.5.1 Influence of COVID-19 12.5.2 Influence of Russia-Ukraine War 13 Raw Material and Industry Chain 13.1 Raw Material of Vortioxetine Hydrobromide Tablets and Key Manufacturers 13.2 Manufacturing Costs Percentage of Vortioxetine Hydrobromide Tablets 13.3 Vortioxetine Hydrobromide Tablets Production Process 13.4 Vortioxetine Hydrobromide Tablets Industrial Chain 14 Shipments by Distribution Channel 14.1 Sales Channel 14.1.1 Direct to End-User 14.1.2 Distributors 14.2 Vortioxetine Hydrobromide Tablets Typical Distributors 14.3 Vortioxetine Hydrobromide Tablets Typical Customers 15 Research Findings and Conclusion 16 Appendix 16.1 Methodology 16.2 Research Process and Data Source 16.3 Disclaimer
It contains all the geographic trends, and market analysis for global market